In fact, it has been postulated that CAFs function as the modulators of crosstalk within ovarian TME involving ECM, angiogenesis, chemoresistance, and invasion in the context of the potential of targeting CAFs as a possible therapeutic approach in ovarian cancers [40]. Here, TBX1 is linked to ovarian cancer.